99 related articles for article (PubMed ID: 22182355)
1. Adolescent acromegaly and decreased arterial distensibility despite successful treatment.
Bassareo PP; Marras AR; Mercuro G
Clin Endocrinol (Oxf); 2012 Jul; 77(1):79-85. PubMed ID: 22182355
[TBL] [Abstract][Full Text] [Related]
2. [Cardiovascular involvement in acromegaly. Apropos of 3 cases].
Cosnay P; Legras A; Garnier LF; Moquet B; Casset D; Fauchier JP; Brochier M
Arch Mal Coeur Vaiss; 1987 Oct; 80(11):1643-50. PubMed ID: 3128208
[TBL] [Abstract][Full Text] [Related]
3. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
Plöckinger U; Quabbe HJ
Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
[TBL] [Abstract][Full Text] [Related]
4. Ambulatory arterial stiffness indexes in acromegaly.
Dassie F; Grillo A; Carretta R; Fabris B; Macaluso L; Bardelli M; Martini C; Paoletta A; Vettor R; Sicolo N; Fallo F; Maffei P
Eur J Endocrinol; 2012 Feb; 166(2):199-205. PubMed ID: 22127491
[TBL] [Abstract][Full Text] [Related]
5. Determinants of arterial compliance in patients treated by hemodialysis.
Level C; Lasseur C; Delmas Y; Cazin MC; Vendrely B; Chauveau P; Gosse P; Combe C
Clin Nephrol; 2001 Dec; 56(6):435-44. PubMed ID: 11770795
[TBL] [Abstract][Full Text] [Related]
6. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
[TBL] [Abstract][Full Text] [Related]
7. [Acromegaly].
Morange I; Jaquet P
Rev Prat; 1996 Jun; 46(12):1482-5. PubMed ID: 8881161
[TBL] [Abstract][Full Text] [Related]
8. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women.
Caron P; Broussaud S; Bertherat J; Borson-Chazot F; Brue T; Cortet-Rudelli C; Chanson P
J Clin Endocrinol Metab; 2010 Oct; 95(10):4680-7. PubMed ID: 20660047
[TBL] [Abstract][Full Text] [Related]
9. [The OASIS study: therapeutic management of acromegaly in standard clinical practice. Assessment of the efficacy of various treatment strategies].
Luque-Ramírez M; Carreño A; Alvarez Escolá C; del Pozo Picó C; Varela da Costa C; Fajardo Montañana C; Gilabert M; Webb S;
Endocrinol Nutr; 2011 Nov; 58(9):478-86. PubMed ID: 22032858
[TBL] [Abstract][Full Text] [Related]
10. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
[TBL] [Abstract][Full Text] [Related]
11. Ventricular-vascular stiffening in patients with repaired coarctation of aorta: integrated pathophysiology of hypertension.
Senzaki H; Iwamoto Y; Ishido H; Masutani S; Taketazu M; Kobayashi T; Katogi T; Kyo S
Circulation; 2008 Sep; 118(14 Suppl):S191-8. PubMed ID: 18824754
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes and mortality of 94 patients with acromegaly.
Trepp R; Stettler C; Zwahlen M; Seiler R; Diem P; Christ ER
Acta Neurochir (Wien); 2005 Mar; 147(3):243-51; discussion 250-1. PubMed ID: 15627919
[TBL] [Abstract][Full Text] [Related]
13. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
14. Arterial stiffness evaluated by measurement of the QKD interval is an independent predictor of cardiovascular events.
Gosse P; Lasserre R; Minifié C; Lemetayer P; Clementy J
Am J Hypertens; 2005 Apr; 18(4 Pt 1):470-6. PubMed ID: 15831355
[TBL] [Abstract][Full Text] [Related]
15. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension.
Leoncini G; Ratto E; Viazzi F; Vaccaro V; Parodi A; Falqui V; Conti N; Tomolillo C; Deferrari G; Pontremoli R
J Hum Hypertens; 2007 Oct; 21(10):802-7. PubMed ID: 17541383
[TBL] [Abstract][Full Text] [Related]
17. Acromegaly: presentation, morbidity and treatment outcomes at a single centre.
Anagnostis P; Efstathiadou ZA; Polyzos SA; Adamidou F; Slavakis A; Sapranidis M; Litsas ID; Katergari S; Selalmatzidou D; Kita M
Int J Clin Pract; 2011 Aug; 65(8):896-902. PubMed ID: 21679284
[TBL] [Abstract][Full Text] [Related]
18. Can ambulatory blood-pressure monitoring provide reliable indices of arterial stiffness?
Gosse P; Papaioanou G; Coulon P; Reuter S; Lemetayer P; Safar M
Am J Hypertens; 2007 Aug; 20(8):831-8. PubMed ID: 17679028
[TBL] [Abstract][Full Text] [Related]
19. The choice of therapy in acromegaly: results of treatment at a tertiary care hospital.
Isidro ML; Castro JA; Penín M; Armenta J; Cordido F
Neuro Endocrinol Lett; 2008 Dec; 29(6):1038-44. PubMed ID: 19112390
[TBL] [Abstract][Full Text] [Related]
20. The influence of different surgical procedures on hypertension after repair of coarctation.
Giordano U; Giannico S; Turchetta A; Hammad F; Calzolari F; Calzolari A
Cardiol Young; 2005 Oct; 15(5):477-80. PubMed ID: 16164785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
